<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1937">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05135949</url>
  </required_header>
  <id_info>
    <org_study_id>2020-147</org_study_id>
    <nct_id>NCT05135949</nct_id>
  </id_info>
  <brief_title>Strength After Elbow Fractures in the Elderly</brief_title>
  <acronym>STAND-UP</acronym>
  <official_title>Strength and Function After Non-operative Treatment of Displaced Olecranon Fractures in the Elderly: Implications of Standing UP From a Seat</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fraser Orthopaedic Research Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fraser Orthopaedic Research Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elderly patients strength and function, specifically the ability to rise from a seat after&#xD;
      either operative or non operative treatment of an mayo type 2 olecranon fracture.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Elderly patients with an olecranon fracture will receive appropriate treatment as determined&#xD;
      by the treating surgeon. Patients will then be assessed at 6 weeks, 6 months and 12 months&#xD;
      post treatment. Assessments include, range of motion, patient reported outcomes and a&#xD;
      strength test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Extension Strength</measure>
    <time_frame>12 Months</time_frame>
    <description>Patients will push down on their distal forearm through a hand held dynamometer, to measure tricep extension strength</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arc of Motion</measure>
    <time_frame>12 months</time_frame>
    <description>Elbow extension and elbow flexion measured with a goniometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mayo Elbow Performance Index</measure>
    <time_frame>12 Months</time_frame>
    <description>An instrument used to test the limitations, caused by pathology, of the elbow during activities of daily living. Higher scores indicate a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disabilities of the Arm, Shoulder, and Hand</measure>
    <time_frame>12 Months</time_frame>
    <description>A 30 Item questionnaire that measures an individuals' ability to complete tasks, absorb forces and severity of symptoms. Lower scores will indicated better outcomes.Lower scores will indicate better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction Score</measure>
    <time_frame>6 weeks, 6 months and 12 months</time_frame>
    <description>Soccer out of 10, higher the score the better the outcome</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Fracture;Elbow</condition>
  <arm_group>
    <arm_group_label>Operative</arm_group_label>
    <description>Internal fixation of the displaced olecranon fracture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non Operative</arm_group_label>
    <description>Conservative treatment as determined by the treating surgeon.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Reported Outcomes</intervention_name>
    <description>Satisfaction, Disabilities of the Shoulder, Arm and Hand</description>
    <arm_group_label>Non Operative</arm_group_label>
    <arm_group_label>Operative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Strength Test</intervention_name>
    <description>Handheld dynamometer to measure tricep extension</description>
    <arm_group_label>Non Operative</arm_group_label>
    <arm_group_label>Operative</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elderly patients for displaced olecranon fractures&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. â‰¥65 years of age&#xD;
&#xD;
          2. Mayo type II olecranon fracture&#xD;
&#xD;
          3. Ambulatory (with or without the use of walking aides)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Additional injuries to the affected arm or contralateral arm&#xD;
&#xD;
          2. Associated nerve injury&#xD;
&#xD;
          3. Dementia or cognitive impairment that inhibits the collection of outcome measures&#xD;
&#xD;
          4. Likely problems, in the judgement of the investigator, with maintaining follow-up&#xD;
             (i.e. patients with no fixed address, not mentally competent to give consent,&#xD;
             intellectually challenged, patients without adequate support, etc.)&#xD;
&#xD;
          5. Injury or previous deficit to the contralateral arm&#xD;
&#xD;
          6. Currently enrolled in any other research study involving drugs or medical devices&#xD;
&#xD;
          7. Open fractures&#xD;
&#xD;
          8. Inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Farhad Moola, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyrsten Payne, BSc</last_name>
    <phone>604-553-3247</phone>
    <email>kyrsten.payne@fraserhealth.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Columbian Hospital</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <zip>V3L 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyrsten Payne</last_name>
      <phone>604-553-3247</phone>
      <email>Kyrsten.Payne@fraserhealth.ca</email>
    </contact>
    <investigator>
      <last_name>Farhad Moola</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Trevor Stone</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Darius Viskontas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kelly Apostle</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dory Boyer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand Perey</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Operative</keyword>
  <keyword>Non Operative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 8, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT05135949/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

